CCMG
VRTX icon

Clark Capital Management Group’s Vertex Pharmaceuticals VRTX Stock Holding History

Clark Capital Management Group’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$217K Sell
487
-43
-8% -$20.1K ﹤0.01% 501
2025
Q4 		$240K Sell
530
-42
-7% -$18.1K ﹤0.01% 469
2025
Q3 		$224K Buy
572
+91
+19% +$38K ﹤0.01% 428
2025
Q2 		$214K Sell
481
-12
-2% -$5.53K ﹤0.01% 410
2025
Q1 		$239K Sell
493
-47
-9% -$21.9K ﹤0.01% 401
2024
Q4 		$217K Sell
540
-63
-10% -$29.2K ﹤0.01% 406
2024
Q3 		$280K Buy
603
+64
+12% +$30.7K ﹤0.01% 366
2024
Q2 		$253K Buy
+539
New +$234K ﹤0.01% 361
2021
Q2 		– Sell
-1,346
Closed -$289K – 370
2021
Q1 		$289K Buy
1,346
+485
+56% +$107K ﹤0.01% 318
2020
Q4 		$203K Hold
861
– – ﹤0.01% 338
2020
Q3 		$234K Buy
861
+10
+1% +$2.76K ﹤0.01% 298
2020
Q2 		$247K Sell
851
-573
-40% -$155K ﹤0.01% 285
2020
Q1 		$339K Sell
1,424
-413
-22% -$94.7K 0.01% 252
2019
Q4 		$402K Sell
1,837
-43
-2% -$8.7K 0.01% 269
2019
Q3 		$319K Buy
1,880
+41
+2% +$7.25K 0.01% 269
2019
Q2 		$337K Buy
1,839
+564
+44% +$98.6K 0.01% 258
2019
Q1 		$235K Buy
+1,275
New +$235K 0.01% 277

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Clark Capital Management Group's VRTX Position: Q1 2026 in Review

Clark Capital Management Group reduced its Vertex Pharmaceuticals (VRTX) stake by 8.1% in Q1 2026, selling an estimated $20.1K and leaving 487 shares worth $217K. The position accounts for ﹤0.01% of the portfolio, ranked #501.

Clark Capital Management Group first reported a position in VRTX in Q1 2019 and has held it in 17 quarters since. The position peaked at $402K in Q4 2019. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • Clark Capital Management Group held 487 shares of Vertex Pharmaceuticals worth $217K as of Q1 2026.
  • Clark Capital Management Group sold 43 Vertex Pharmaceuticals shares in Q1 2026, an estimated $20.1K.
  • Vertex Pharmaceuticals made up ﹤0.01% of Clark Capital Management Group's portfolio in Q1 2026, its #501 holding.
  • Clark Capital Management Group first reported a position in Vertex Pharmaceuticals in Q1 2019 and has held it in 17 quarters since.
  • Clark Capital Management Group's Vertex Pharmaceuticals position peaked at $402K in Q4 2019.
  • 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Clark Capital Management Group's 13F filing for Q1 2026, filed 15 May 2026.